Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance. | Nat Commun | 2024 | 38177131 | PubTator, text mining | PubMed |
| Discovery of the cereblon-recruiting tubulin PROTACs effective in overcoming Taxol resistance in vitro and in vivo. | Eur J Med Chem | 2024 | 38171146 | PubTator, text mining | PubMed |
| Trends in Neosubstrate Degradation by Cereblon-Based Molecular Glues and the Development of Novel Multiparameter Optimization Scores. | J Med Chem | 2024 | 38170610 | PubTator, text mining | PubMed |
| Induced protein degradation for therapeutics: past, present, and future. | J Clin Invest | 2024 | 38165043 | PubTator, text mining | PubMed |
| DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma. | J Exp Clin Cancer Res | 2024 | 38163876 | PubTator, text mining | PubMed |
| Thrombospondin-1 is an endogenous substrate of cereblon responsible for immunomodulatory drug-induced thromboembolism. | Blood Adv | 2024 | 38163319 | PubTator, text mining | PubMed |
| C/EBPβ-induced lymphoid-to-myeloid transdifferentiation emulates granulocyte-monocyte progenitor biology. | Stem Cell Reports | 2024 | 38157851 | PubTator, text mining | PubMed |
| Old drug, new use: The thalidomide-based fluorescent probe for hydrazine detection. | Spectrochim Acta A Mol Biomol Spectrosc | 2024 | 38154305 | PubTator, text mining | PubMed |
| Protein degraders - from thalidomide to new PROTACs. | J Biochem | 2024 | 38140952 | PubTator, text mining | PubMed |
| Lenalidomide use in multiple myeloma (Review). | Mol Clin Oncol | 2024 | 38125742 | PubTator, text mining | PubMed |
| Development of Phenyl-substituted Isoindolinone- and Benzimidazole-type Cereblon Ligands for Targeted Protein Degradation. | Chembiochem | 2024 | 38116854 | PubTator, text mining | PubMed |
| MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial. | Blood Adv | 2024 | 38113470 | PubTator, text mining | PubMed |
| Discovery of highly efficient CRBN-recruiting HPK1-PROTAC as a potential chemical tool for investigation of scaffolding roles in TCR signaling. | Bioorg Chem | 2024 | 38086239 | PubTator, text mining | PubMed |
| NAK-associated protein 1/NAP1 activates TBK1 to ensure accurate mitosis and cytokinesis. | J Cell Biol | 2024 | 38059900 | PubTator, text mining | PubMed |
| Rationally designed approaches to augment CAR-T therapy for solid tumor treatment. | Bioact Mater | 2024 | 38059121 | PubTator, text mining | PubMed |
| Targeting Senescent Cells as Therapy for CKD. | Kidney360 | 2024 | 38049936 | PubTator, text mining | PubMed |
| Molecular glues targeting GSPT1 in cancers: A potent therapy. | Bioorg Chem | 2024 | 38029571 | PubTator, text mining | PubMed |
| The reversible inhibitor SR-4835 binds Cdk12/cyclin K in a noncanonical G-loop conformation. | J Biol Chem | 2024 | 38016516 | PubTator, text mining | PubMed |
| Discovery of LWY713 as a potent and selective FLT3 PROTAC degrader with in vivo activity against acute myeloid leukemia. | Eur J Med Chem | 2024 | 38007910 | PubTator, text mining | PubMed |
| ETV4-Dependent Transcriptional Plasticity Maintains MYC Expression and Results in IMiD Resistance in Multiple Myeloma. | Blood Cancer Discov | 2024 | 37934799 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=24